60% of Revenue from Wang Yibo? YH ENT Responds: Proportion Gradually Declining

Deep News
2025/11/06

On November 6, recent reports claimed that Wang Yibo would not renew his contract with YH ENT upon expiration. Sources indicated that in 2024, YH ENT's total revenue reached 765 million yuan, with Wang Yibo—dubbed the "top cash cow"—contributing over 60%. Additional data revealed that his contribution has surged annually since 2019, rising from 16.8% in 2019 to 56.8% in 2022 and hitting the 60% mark in 2024.

When asked whether Wang Yibo's potential departure would impact the company's stock price, YH ENT's investor relations department stated, "The current stock performance remains stable, with recent gains." They added, "His (Wang Yibo) revenue share within the company is gradually decreasing, and his contract was originally set to expire next year. Please await our official announcement at that time."

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10